Alexander Otahal

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Knee Osteoarthritis

Extracellular Matrix

Mesenchymal Stem Cells

Top Venues

Stem cell research & therapy

Scientific reports

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Alexander Otahal, Karina Kramer, Markus Neubauer, Slavomira Gulová, Zsombor Lacza, Stefan Nehrer, Andrea De Luna
Culture of Hoffa fat pad mesenchymal stem/stromal cells on microcarrier suspension in vertical wheel bioreactor for extracellular vesicle production. Stem cell research & therapy 15 (1) (2024)
Alexander Otahal, Karina Kramer, Markus Neubauer, Slavomira Gulová, Zsombor Lacza, Stefan Nehrer, Andrea De Luna
Culture of Hoffa fat pad mesenchymal stem/stromal cells on microcarrier suspension in vertical wheel bioreactor for extracellular vesicle production. Stem cell research & therapy 15 (1) (2024)
Alexander Otahal, Karina Kramer, Markus Neubauer, Slavomira Gulová, Zsombor Lacza, Stefan Nehrer, Andrea De Luna
Culture of Hoffa fat pad mesenchymal stem/stromal cells on microcarrier suspension in vertical wheel bioreactor for extracellular vesicle production. Stem cell research & therapy 15 (1) (2024)
Alexander Otahal, Karina Kramer, Markus Neubauer, Slavomira Gulová, Zsombor Lacza, Stefan Nehrer, Andrea De Luna
Culture of Hoffa fat pad mesenchymal stem/stromal cells on microcarrier suspension in vertical wheel bioreactor for extracellular vesicle production. Stem cell research & therapy 15 (1) (2024)
Alexander Otahal, Karina Kramer, Olga Kuten Pella, Lukas B Moser, Markus Neubauer, Zsombor Lacza, Stefan Nehrer, Andrea De Luna
Effects of Extracellular Vesicles from Blood-Derived Products on Osteoarthritic Chondrocytes within an Inflammation Model. International journal of molecular sciences 22 (13) (2021)
Alexander Otahal, Duygu Aydemir, Erwin Tomasich, Christoph Minichsdorfer
Delineation of cell death mechanisms induced by synergistic effects of statins and erlotinib in non-small cell lung cancer cell (NSCLC) lines. Scientific reports 10 (1) (2020)